Biomedical applications of maghemite ferrofluid (Q43868865)

27 November 2017

1 reference

title

Biomedical applications of maghemite ferrofluid (English)

1 reference

27 November 2017

Halbreich A

1

1 reference

27 November 2017

Roger J

2

1 reference

27 November 2017

Pons JN

3

1 reference

27 November 2017

Geldwerth D

4

1 reference

27 November 2017

Da Silva MF

5

1 reference

27 November 2017

Roudier M

6

1 reference

27 November 2017

Bacri JC

7

1 reference

27 November 2017

publication date

1 May 1998

1 reference

27 November 2017

1 reference

27 November 2017

volume

80

1 reference

27 November 2017

issue

5-6

1 reference

27 November 2017

page(s)

379-390

1 reference

Iron-dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Magnetic biospecific affinity adsorbents for immunoglobulin and enzyme isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Ferromagnetic contrast agents: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

The sub-cellular localization of annexin V in cultured chick-embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Protein involvement in transmembrane lipid asymmetry

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Abnormalities in membrane phospholipid organization in sickled erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Malaria: phosphatidylserine expression is not increased on the surface of parasitized erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Annexin V binding to mouse erythrocytes following infection with Plasmodium parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

1 reference

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Presenilin-1 polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

No change in viscosity of lipid phase of RBC membrane in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Platelet and erythrocyte membrane changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Red blood cells from Alzheimer patients and from normal subjects discerned by cell electrophoresis in an aqueous polymer solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Differential electrophoretic behavior in aqueous polymer solutions of red blood cells from Alzheimer patients and from normal individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Membrane modifications of red blood cells in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Kinetics of hemolysis of normal and abnormal red blood cells in glycerol-containing media

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Biochemical lesions in copper-deficient rats caused by secondary iron deficiency. Derangement of protein synthesis and impairment of energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Reduced rate of ATP catabolism and the enhanced amino acid incorporating activity of regenerating rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2800%2980006-1

7 January 2021

10.1016/S0300-9084(00)80006-1

Identifiers

DOI

1 reference

27 November 2017

1 reference